Sully Funding: How Much Did They Raise & Key Investors

How Much Did Sully Raise?
Funding & Key Investors

Sully, a prominent player in the health tech landscape, has successfully secured a major strategic investment, bringing its cumulative capital infusion to $31.9M. This latest financing round, which accounts for $21.8M, underscores the market's growing confidence in the company's ability to address critical inefficiencies within the medical sector. By prioritizing the integration of advanced language models into clinical environments, Sully continues to solidify its position as a transformative force in digital health infrastructure.

The company's trajectory, marked by consistent growth since its inception, reflects a broader industry trend toward the automation of physician workflows. With this latest injection of capital, Sully is well-positioned to scale its operations and further refine its proprietary technology, which is designed to alleviate the mounting administrative burden faced by healthcare providers globally.

What is Sully?

Sully

Software

Healthcare Software

Sully operates at the intersection of artificial intelligence and clinical operations, focusing on the automation of physician workflows. The company's core value proposition lies in its ability to leverage sophisticated language models to streamline documentation processes, effectively allowing medical professionals to reclaim approximately three hours of their daily schedule. By reducing the time spent on manual administrative tasks, Sully enables doctors to shift their focus back to patient care, thereby improving both operational efficiency and clinical outcomes. As a health tech innovator, the firm is addressing a significant pain point in the modern healthcare system, where burnout and administrative fatigue remain persistent challenges for practitioners.

How much funding has Sully raised?

Sully has raised a total of $31.9M across 3 funding rounds:

2019

Angel/Seed

$180K

2021

Series A

$9.9M

2025

Series A

$21.8M

Angel/Seed (2019): $180K, investors not publicly disclosed

Series A (2021): $9.9M, investors not publicly disclosed

Series A (2025): $21.8M supported by Sahin Boydas

Key Investors in Sully

Sahin Boydas

An active investor and entrepreneur with a focus on high-growth technology ventures and digital transformation initiatives.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Sully?

Looking ahead, the recent capital influx will likely be directed toward aggressive product development and market expansion. As Sully scales its platform, the focus will shift toward enhancing the interoperability of its language models with existing electronic health record systems, ensuring seamless adoption across diverse clinical settings. Furthermore, the company is expected to invest in talent acquisition to bolster its engineering and data science teams, which are critical for maintaining its competitive edge in the rapidly evolving health tech market. By continuing to prioritize the reduction of physician documentation time, Sully is poised to become an essential component of the modern digital hospital, driving long-term value for both healthcare institutions and the patients they serve.

See full Sully company page

See More Financial Insights